Biotec Expands Ultra Low Temperature Storage Space
Biotec Services said that the ultra low temperature storage space is increased to 300% which is expected to meet the needs of its clients who use its import,
HAYA Therapeutics has secured fast track designation from the US Food and Drug Administration (FDA) for its investigational therapy, HTX-001, to treat symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM).